The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review
Top Cited Papers
- 11 February 2022
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 63 (6) , e725-e738
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Developing core outcome sets for clinical trials: issues to considerTrials, 2012
- Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trialThe Lancet Oncology, 2011
- The Pharmacology of Lysergic Acid Diethylamide: A ReviewCNS Neuroscience & Therapeutics, 2008
- Human hallucinogen research: guidelines for safetyJournal of Psychopharmacology, 2008
- Embracing Cicely Saunders's concept of total painBMJ, 2005
- Psychotropic Drugs in Terminally Ill Patients: A Review of the Clinical and Research LiteratureOMEGA - Journal of Death and Dying, 2004
- The pharmacology of psilocybinAddiction Biology, 2002
- DPT as an Adjunct in Brief Psychotherapy with Cancer PatientsOMEGA - Journal of Death and Dying, 1980
- The Need for a New Medical Model: A Challenge for BiomedicineScience, 1977
- The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer PatientsJournal of Psychedelic Drugs, 1977